Skip to main content

Our Mission

Our Mission Video Thumbnail

Our Mission

It is our mission to one day end the suffering caused by neurodegenerative diseases. Every day we strive for better therapies. We question the unquestioned, always in search of new solutions.

Group photo of Amylyx team members standing at the Red Sox Stadium

Who we are

Amylyx is a global pharmaceutical company based in Cambridge, Massachusetts, that is dedicated to the discovery and development of potential treatments for neurodegenerative diseases. We pursue unconventional approaches through lasting collaborations with industry leaders, scientists, doctors, research organizations, and the communities impacted by these relentlessly progressive diseases.

Picture of Josh Cohen & Justin Klee standing

Where we began

The journey started with a simple question. While studying neurodegenerative diseases at Brown University, Amylyx Co-CEO Josh Cohen wondered, “Why do neurons die?” It seemed like such an obvious starting point, yet the solution was nowhere to be found. Upon examining the available research, Josh and a classmate—Co-CEO Justin Klee—decided to pursue the question further, relentlessly looking for answers. After years of work, they eventually accumulated enough data to pursue next steps and begin their own original research. Since 2013, the partnership between Josh and Justin evolved and gave rise to Amylyx, a rapidly growing company with the same curiosity and resilience as the day the company began.

Our path to progress

See the strides we've made so far since we were founded in 2013.  Click on the graphic below to enlarge.

Our origin story

The Amylyx Story
Our Values
Neuron Image

Latest News

Built on Connections

We are all united in the fight against neurodegenerative diseases - true collaboration can change the course of a thought or an idea, or even the development of a therapy. Through strategic collaborations, participant-centric clinical trial design, and the sharing of ideas with open outreach, we can make a lasting impact in the neurodegenerative disease community.

Be the change

Group photo of Amylyx team standing on stairs together outdoors wearing face masks

Be the change

We've made some great strides in a short amount of time, but the work has just begun. If you'd like to join us in our mission, you can learn more about our culture and open positions below.